Cargando…
SLC22A1 rs622342 Polymorphism Predicts Insulin Resistance Improvement in Patients with Type 2 Diabetes Mellitus Treated with Metformin: A Cross-Sectional Study
BACKGROUND: Metformin is the most widely used oral antidiabetic agent and can reduce insulin resistance (IR) effectively. Organic cation transporter 1 (encoded by SLC22A1) is responsible for the transport of metformin, and ataxia-telangiectasia-mutated (ATM) is a gene relating to the DNA repair and...
Autores principales: | Wu, Kunrong, Li, Xiaoli, Xu, Yuedong, Zhang, Xiaoqian, Guan, Ziwan, Zhang, Shufang, Li, Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7231067/ https://www.ncbi.nlm.nih.gov/pubmed/32454819 http://dx.doi.org/10.1155/2020/2975898 |
Ejemplares similares
-
The influence of SLC22A1 rs622342 and ABCC8 rs757110 genetic variants on the efficacy of metformin and glimepiride combination therapy in Egyptian patients with type 2 diabetes
por: Ebid, Abdel-Hameed I. M., et al.
Publicado: (2019) -
Population pharmacokinetics and dosing optimization of metformin in Chinese patients with type 2 diabetes mellitus
por: Li, Ling, et al.
Publicado: (2020) -
rs622342 in SLC22A1, CYP2C9*2 and CYP2C9*3 and Glycemic Response in Individuals with Type 2 Diabetes Mellitus Receiving Metformin/Sulfonylurea Combination Therapy: 6-Month Follow-Up Study
por: Naja, Khaled, et al.
Publicado: (2020) -
The Impacts of SLC22A1 rs594709 and SLC47A1 rs2289669 Polymorphisms on Metformin Therapeutic Efficacy in Chinese Type 2 Diabetes Patients
por: Xiao, Di, et al.
Publicado: (2016) -
SLC22A3 rs2048327 Polymorphism Is Associated with Diabetic Retinopathy in Caucasians with Type 2 Diabetes Mellitus
por: Grbić, Emin, et al.
Publicado: (2023)